TrialJAMA oncology2021
Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer: An Ancillary Study of the NRG/RTOG 9601 Randomized Clinical Trial.
Felix Y Feng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
86 papers cite itlatest 60 shown
this paperpooled ittrialcites it